COVID-19 No.1

N/A

Report date: 2025/08/04 17:43:38

Base Information

Drug NameCOVID-19 No.1
Drug Alias NameCOVID-19 treatment neutralizing antibody (Jecho Biopharmaceuticals)COVID-19 No.1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJecho Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJecho Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A